Sunday, January 28, 2024 12:41:15 PM
You are frantically posting nonsense far too frequently—nothing you post is substantive or substantiated. You are here spreading rumors and nobody is listening to you—we are listening to the regulators and licensed independent peer reviewers whose analyses are published by reputable internationally recognized medical journals.
https://www.prnewswire.com/news-releases/northwest-biotherapeutics-announces-that-a-marketing-authorization-application-has-been-submitted-to-the-uk-mhra-for-dcvax-l-for-glioblastoma-302021038.html
March 2023
https://www.prnewswire.com/news-releases/northwest-biotherapeutics-and-advent-bioservices-announce-receipt-of-license-for-commercial-manufacturing-at-sawston-uk-facility-301776725.html
February 2022
https://www.prnewswire.com/news-releases/northwest-biotherapeutics-announces-commencement-of-cancer-vaccine-production-at-its-sawston-uk-facility-301484857.html
August 2022
https://www.prnewswire.com/news-releases/northwest-biotherapeutics-announces-approval-of-pediatric-investigation-plan-pip-by-mhra-301610850.html
July 2022
https://www.prnewswire.com/news-releases/northwest-biotherapeutics-announces-filing-of-application-for-license-for-commercial-manufacturing-at-sawston-uk-facility-301581737.html
December 2022
https://www.prnewswire.com/news-releases/northwest-biotherapeutics-announces-mhra-approval-of-license-for-gmp-manufacturing-at-sawston-uk-facility-301449083.html
https://finance.yahoo.com/news/northwest-biotherapeutics-announces-dr-linda-140000962.html
https://jamanetwork.com/journals/jamaoncology/fullarticle/2798847
“Online message boards have become a hotspot for the dissemination of information about over-the-counter (OTC) stocks, particularly in sectors like biotechnology. Unfortunately, this platform is also rife with disinformation, which can mislead investors, especially those who are not well-versed in the intricate details of biotech investments or the science behind them.
**How Online Message Boards Spread Disinformation:**
1. **Anonymity and Lack of Accountability**: Many online forums allow users to post anonymously. This lack of accountability makes it easier for individuals to spread false or misleading information without facing direct consequences.
2. **Herd Mentality and Echo Chambers**: These platforms often foster a herd mentality, where a single opinion or piece of misinformation can be amplified as it gets echoed and re-shared by multiple users, creating a false sense of consensus or credibility.
**Avoiding the Trap of Disinformation:**
1. **Critical Analysis of Sources**: Always scrutinize the source of the information. Anonymous posts or unverified claims should be treated with skepticism.
2. **Seeking Expert Opinions and Reputable Sources**: For biotech stocks, information should ideally come from experts in the field, such as licensed oncologists, or from peer-reviewed medical journals. Websites of regulatory bodies like the FDA or NIH also provide reliable information.
3. **Understanding the Science**: Basic knowledge of biotechnology and medical science can help in discerning credible information. This doesn't mean becoming an expert but having enough understanding to sense when information seems implausible.
4. **Diversifying Information Channels**: Relying solely on message boards for investment decisions is risky. Investors should diversify their sources, including financial news websites, official company reports, and analysis from reputable financial analysts.
**Examples of Reputable Sources for Biotech Information:**
- **Peer-Reviewed Medical Journals**: Journals like The New England Journal of Medicine, The Lancet, and JAMA offer high-quality, vetted information on the latest research and developments.
- **Statements from Licensed Oncologists**: Comments or analysis from medical professionals in the field of oncology can provide insight into the viability and potential of biotech stocks, especially those focused on cancer research.
- **Regulatory Body Announcements**: Information from bodies like the FDA, which approves new treatments and drugs, is crucial for understanding the legitimacy and potential of biotech companies.
In summary, while online message boards can be a useful tool for gathering diverse opinions and information, they are also fertile ground for disinformation, particularly regarding OTC stocks in complex fields like biotechnology. It is crucial for the public to approach such platforms with a critical eye, seeking information from reputable and expert sources to make informed decisions.”
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173629584
Believe carefully. This is the greatest and most powerful lesson that I have learned since arriving on Earth. Examine what you believe about yourself most importantly, and then believe carefully as you interact with the world.
Recent NWBO News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/03/2024 08:01:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/13/2024 08:01:24 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2024 09:06:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/08/2024 08:30:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2024 02:42:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/30/2024 11:49:38 PM
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM
Unitronix Corp Unveils Cryptocurrency Investment Portfolio Strategy • UTRX • Oct 2, 2024 8:40 AM
Integrated Ventures, Inc Reports Total 2024 Revenues Of $5,863,935 vs $3,862,849 for 2023. • INTV • Oct 1, 2024 9:00 AM
Nightfood Signs Letter of Intent to Acquire Los Angeles Cooking School, Integrating Automation and Robotics with World-Class Culinary Training • NGTF • Oct 1, 2024 8:30 AM
ZenaTech, Inc. (NASDAQ: ZENA) To Commence Trading Today • COOP • Oct 1, 2024 7:00 AM
Element79 Gold Corp secures loi for launching tailings reprocessing business in Arequipa, Peru • ELMGF • Oct 1, 2024 6:38 AM